A combination table (1) arranged for use as a baby changing table or a desk or a partition, including either two vertical side members (2) and one horizontal table top (5) and at least one horizontal shelf (7); or two vertical side members (2) and one horizontal table top (5) and one horizontal crossbeam (10) and alternatively one or more shelves (7) mounted between the side members (2); or at lea...

The invention relates to crystalline salts of the compound (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3R,5S)-3,5-dihydroxyhept-6-enoic acid, as well as processes for their manufacture, pharmaceutical compositions containing them, and their uses.

A compound of formula: where Ar 1 , Ar 2 , X, R 3 , and m are as disclosed herein or a pharmaceutically acceptable salt thereof (a "Tetrahydropiperidyl Compound"); compositions comprising an effective amount of a Tetrahydropiperidyl Compound; and methods for treating or preventing pain, Ul, an ulcer, IBD, IBS, an addictive disorder, Parkinson's disease, parkinsonism, anxiety, epilepsy, stroke, ...

2-amino-1,3-thiazole derivatives represented by formula (I) or (II): where R, R1, R2 and R3 are defined herein, or pharmaceutically acceptable salts thereof are useful as, for example, the treatment of cancer, cell proliferative disorders, Alzheimer's disease, viral infections, auto-immune diseases or neurodegenerative diseases.

A process is provided for isolating a protein component of animal muscle tissue by mixing a particulate form of the tissue with an acidic aqueous liquid having a pH below about 3.5 to produce a protein rich solution substantially free of myofibrils and sarcomere tissue structure. The protein rich aqueous solution can be treated to effect protein precipitation, followed by protein recovery.

(-)-5-(3-Chlorophenyl)-alpha-(4-chlorophenyl)-alpha-(1-methyl-1H-imidazol-5-yl)tetrazolo-[1,5-a]quinazoline-7-methanamine and its pharmaceutically acceptable acid addition salts, and the use of such compounds in medicine especially for the treatment of cancer

The invention relates to the combination of ciclesonide with formoterol.

The invention relates to a compound of formula (1): in which R¹ and R² each independently represent a C_1-6alkyl, C_3-6alkenyl, C_3-6cycloalkylC_1-3alkyl or C_3-6cycloalkyl; each of which is optionally substituted by 1 to 3 halogen atoms; R³ is isoxazolidin-2-ylcarbonyl or tetrahydroisoxazin-2-ylcarbonyl wherein eac...

Die Erfindung betrifft ein elektrochemisches Elektrolytreinigungsverfahren unter Verwendung von Kunststoff-Diamant-Verbundelektroden. Beim Elektrolyt handelt es sich üblicherweise um Abwässer aus chemischen oder elektrochemischen Verfahren. Die bipolaren Kunststoff-Diamant-Verbundelektroden (2) werden dabei in speziell gekrümmten Ausführungsformen zu Zellstapeln zusammengebaut und bilden so den Ke...

A method and apparatus for calculating RQuickPage in a wireless communication system characterized in that , determining the value of the PreferredQuick-PageEnabled field and calculating RQuickPage wherein RQuickPage is used by the lower Medium Access Layer (MAC) Sublayer to determine if a quick page is received.

La presente invención se refiere parametros de formulación y condiciones de manufacturación para composiciones farmaceuticas estables que comprenden N-{4 (2,2-dimetil-propionil)-(5R)-5-[(2-etilamino-etansulfonilamino)-metil]-5-fenil-4,5-dihidro-[1,3,4]tiadiazol-2-il}-2,2-dimetil-propionamida que minimiza la conversión quiral estable a la forma enantiomerica S menos activa.; The present invention p...

Un anticuerpo o fragmento de union a antigeno de un anticuerpo humano que se une especificamente a factor de crecimiento de nervio humano (NGF) con una KD de 5 pM o menus, que no reacciona de forma cruzada con neurotrofina-3 (NT-3, y que se une a NGF humano con una KD aproximadamente de 2 a 10 veces mayor que la correspondiente a la union del anticuerpo o fragmento con NGF de rata o de raton. Los ...

La presente invención proporciona un nuevo derivado de pirazol y un antagonista del receptor de andrógeno que contiene el derivado. La presente invención proporciona un compuesto representado por la formula (I') en donde R1 es un atomo de hidrógeno, un grupo unido a traves de un atomo de carbono, un grupo unido a traves de un atomo de nitrogeno, un grupo unido a traves de un atomo de oxigeno, o un...

During operation radio frames are divided into a plurality of subframes. Data is transmitted over the radio frames within a plurality of subframes, and having a subframe type selected from a plurality of subframe types. Each subframe type having a same time duration and being distinguished by having a differing number of OFDM symbols or a differing number of single carrier FDMA symbols.

In a two-wheeled motor vehicle, lifting of the rear wheel caused by quick braking operation is reliably prevented. The amount of variation in vehicle body deceleration is calculated based on detection signals from wheel speed sensors (45, 46)(S102), and whether or not the calculated value exceeds a predetermined value (K1) is determined (S104). When it is determined that the predetermined value (K...

A brake control method for a two-wheeled motor vehicle, which reliably prevents the rear wheel from lifting again immediately after its landing on the ground. When the completion of an output of a detection signal according to detection of lifting of the rear wheel is determined (S102), brake pressure is reduced, or more particularly, a pressure increase gradient of wheel cylinder pressure of the ...

Information recording media 101 and 102 usable for either a first recording density D1 or a second recording density D2 each include a user data area 106 in which user data is to be recorded, a first defect management information area 108 in which first defect management information for managing a defect area in the user data area is to be recorded, and a second defect management information area ...